慢性肾脏病与心血管疾病对高血压患者预期寿命及医疗服务利用的负担:香港华人队列研究
CKD、心脏病和卒中的组合越多,死亡风险和医疗费用递增、预期寿命递减;严重CKD的负担超过心脏病与卒中的联合效应。
要点
- 中度CKD、心脏病、卒中每增加一种,60岁预期寿命分别减少约5、10、15年
- 三种疾病组合的死亡相对风险分别增加约70%、160%、290%
- 严重CKD的死亡风险与医疗费用增幅超过心脏病与卒中的联合效应
核心结论
- 严重CKD的死亡风险与医疗费用增幅极高,超过心脏病与卒中的联合效应。
- 中度CKD、心脏病、卒中的死亡风险与费用各自相似,任意组合大致呈乘法效应。
- 为降低高血压患者死亡与医疗费用,CKD预防与干预应与心血管疾病同等优先。
研究设计与样本
- 回顾性队列研究,纳入506849例香港华人高血压成人。
- 采用Cox回归分析全因死亡与中度CKD(eGFR 30-59 ml/min per 1.73 m2)、严重CKD(eGFR 15-29 ml/min per 1.73 m2)、心脏病和卒中组合的关联。
主要发现
- 随访期间共发生55666例死亡。
- 合并症数量增加与死亡风险、医疗费用递增及预期寿命递减相关。
- 与无CKD及心血管疾病者相比,合并一种、两种、三种疾病(心脏病、卒中、中度CKD)的死亡相对风险分别增加约70%、160%、290%。
- 对应直接医疗费用分别增加约70%、160%、280%。
- 60岁预期寿命分别减少约5、10、15年;严重CKD负担更高。
临床怎么用
- 在高血压患者管理中,应将CKD预防与干预提升至与心血管疾病同等优先级别。
- 对合并CKD、心脏病或卒中的高血压患者,需关注死亡风险、医疗费用及预期寿命的叠加负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The relative effects of combinations of CKD, heart disease, and stroke on risk of mortality, direct medical costs, and life expectancy are unknown. METHODS: In a retrospective cohort study of 506,849 Chinese adults in Hong Kong with hypertension, we used Cox regressions to examine associations between all-cause mortality and combinations of moderate CKD (eGFR of 30-59 ml/min per 1.73 m2), severe CKD (eGFR of 15-29 ml/min per 1.73 m2), heart disease (coronary heart disease or heart failure), and stroke, and modeling to estimate annual public direct medical costs and life expectancy. RESULTS: Over a median follow-up of 5.8 years (2.73 million person-years), 55,666 deaths occurred. Having an increasing number of comorbidities was associated with incremental increases in mortality risk and medical costs and reductions in life expectancy. Compared with patients who had neither CKD nor cardiovascular disease, patients with one, two, or three conditions (heart disease, stroke, and moderate CKD) had relative risk of mortality increased by about 70%, 160%, and 290%, respectively; direct medical costs increased by about 70%, 160%, and 280%, respectively; and life expectancy at age 60 years decreased by about 5, 10, and 15 years, respectively. Burdens were higher with severe CKD. CONCLUSIONS: This study demonstrated extremely high mortality risk and medical cost increases for severe CKD, exceeding the combined effects from heart disease and stroke. Mortality risks and costs for moderate CKD, heart disease, and stroke were similar individually and roughly multiplicative for any combination. These findings suggest that to reduce mortality and health care costs in patients with hypertension, CKD prevention and intervention merits priority equal to that of cardiovascular disease.
引用
- Wan EYF, Yu EYT, Chin WY, et al. Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients. J Am Soc Nephrol. 2019. PMID: 31492808. doi:10.1681/ASN.2018101037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。